UBE2I and ovarian cancer: Our group has previously reported that Wild type BRCA1a/1b proteins unlike the pathogenic mutants to bind Ubc9, a sole SUMO conjugase and perform its function as a tumor suppressor in TNBC and ovarian cancer cells [34, 41].